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1. Introduction
  The infection of hepatocytes by sporozoites within the 
mammalian host is an important step in the Plasmodium 
life cycle[1]. Several studies have reported that host 
cell infection is preceded by the traversal of several 
hepatocytes by the malarial parasites[2,3] . As a result, these 
hepatocytes are wounded due to membrane rupturing. 
After malaria sporozoites are injected into the mammalian 
host by infected mosquitoes, sporozoites must firstly infect 
hepatocytes to establish mammalian cycle of a malarial 
infection[1].  Sporozoites initially traverse the cytosol of some 
hepatocytes until finally invading one of them by forming a 
parasitophorous vacuole[2-4]. During the migrated process, 
some of the migrated hepatocytes die, but most of them 
survive. When the plasma membrane of a hepatocyte is 
wounded, some growth factors and other proteins stored in 
the cytosol are released to the extracellular environment[5-7]. 
In addition, hepatocyte injury may also accelerate the 
expression of certain growth factors, which can be secreted 
and further influence sporozoite development[6].Therefore, 
hepatocyte wounding by sporozoite migration promotes 
synthesize and release growth factors and other proteins 
that may have the capability of influencing the neighboring 
environment and helping sporozoite development in 
mammalian host. In previous studies, hepatocyte growth 
factor (HGF) has been shown to be one of the well-
characterized growth factors that are released after 
injury[5-8]. Therefore, it is reasonable to think that HGF may 
render neighboring hepatocytes susceptible to infection. In 
the current study, we found that HGF and its receptor are 
involved into the sporozoite development in liver and that 
activation of HGF signaling pathway is necessary for malaria 
infection.
2. Materials and methods
2.1. Parasites and preparation of hepatocytes
  Plasmodium berghei (P. berghei) (MR4, USA) sporozoites 
were obtained from dissection of Anopheles stephensi 
mosquito (breed in our laboratory) salivary glands infected 
with P. berghei as previous report[9]. Primary hepatocytes 
were prepared as in a previously described study[10]. Briefly, 
hepatocytes were isolated by collagenase H perfusion 
of mouse liver lobules and purified over a 60% Percoll 
gradient. Cells (in William's medium with 10% FCS) were 
seeded in chamber slides and incubated at 37 曟 with 5% 
CO2 for 24 h.
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2.2. Sporozoite infection 
  Sporozoites (5伊104) were added to hepatocyte monolayers 
(2伊105) for 24 h, before fixation and staining with 
monoclonal antibody (Santa Cruz biotechnology, USA) to 
detect the exoerythrocytic forms (EEFs) and infection was 
quantified by counting the number of EEFs as reported in 
previous study[11]. All infections were done in triplicate and 
repeated three times. To detect the infection rate affected 
by HGF or antibodies against HGF, recombinant murine HGF 
(R&D Systems, USA) or monoclonal antibodies against HGF 
(Santa Cruz biotechnology, USA) were added and the EEFs 
were observed.
2.3. Determination of HGF levels
  Western blot and ELISA were used to determine the levels 
of HGF in the media of infected hepatocyte monolayers 
and performed as we reported before[12-14]. For ELISA, 
sporozoite-infected media were collected at different time 
points. Ninety-six-well plates were coated with monoclonal 
anti-HGF antibodies (100 毺L/well, 1 毺g/mL) in coating 
buffer (carbonate-bicarbonate pH 9.6) overnight at 4 曟. 
Plates were washed with PBST (0.05% Tween 20 in PBS) and 
blocked 1 hour at 37 曟 with 200 毺L/well 1% bovine serum 
albumin (BSA) in PBST. After washing, sporozoite-infected 
media diluted serially in PBS were added and incubated 
for 2 hours at 37 曟, followed by a dilution of anti-mouse 
IgG subclass antibodies (Santa Cruz biotechnology, USA) 
conjugated with alkaline phosphatase. Enzyme activity was 
measured with an ELISA reader (Bio-tek Laboratories Inc., 
USA). For Western blot analysis, sporozoite-infected media 
were separated by sodium dodecylsulfate/polyacrylamide 
gel electrophoresis (SDS/PAGE). The proteins in the gel were 
transferred onto a polyvinylidene fluoride (PVDF) membrane 
(Bio-Rad, USA). The membrane blots were blocked at 
4 曟in 5% nonfat dry milk, washed, and probed with anti-
HGF antibodies at 1÷500. The blots were then washed 
and incubated with a biotinylated secondary antibody 
(biotinylated rat anti-mouse IgG), followed by transfer to 
Vectastain ABC (Vector Laboratories, USA).
2.4. HGF staining in infected hepatocytes
  For in vitro staining of HGF, sporozoites were added to 
monolayer of primary hepatocytes for 1 h in the presence of 
lysine-fixable dextran and 1 mg/mL of FITC-conjugated. 
Primary hepatocytes were then washed, fixed with 4% 
paraformnldehyde and stained with monoclonal antibody 
to HGF (Sigma, USA) followed by rhodamine conjugated 
secondary antibody (Santa Cruz biotechnology, USA) as previous 
reported[8].
2.5. Preparation of conditional media
  Preparation of conditional media was done as previous 
reported[8]. Conditional medium results from the incubation 
of P. berghei sporozoites (105) with hepatocyte monolayers 
(2伊105) at 37 曟 for 1 h. The absence of infectious 
aporazoites was verified by adding conditional media to 
hepalocytes and determining infection.
2.6. HGF receptor (MET) immunoprecipitation and detection 
of phosphorylation status
  Primary hepatocytes (8伊l05) were incubated or not with 4
伊l05 P. berghei sporozoites and then lysed for 20 mins at 
4 曟 in 200 毺L of a buffer containing 5 mM EDTA, 50 
mM HEPES (pH 7.4), 10% glycerol, 150 mM NaCl, 2 mM 
EGTA and 1% Triton伊100 in the presence of phosphatase 
inhibitors and protease. Extracts were clarified at 
15 000 g for 15 mins and incubated with protein antibody 
to mouse MET (1 毺g/mL; Santa Cruz Biotechnology) and 
G-Sepharose for 4 h at 4 曟 with gentle rotation. Samples 
were then centrifuged, re-suspended in 50 毺L of 2伊
Laemnrli buffer and boiled for 5 mins. Extracts were 
electrophoresed on SDS-PAGE and transferred onto PVDF 
membranes. Blots were probed with antibodies to MET (Santa 
Cruz biotechnology, USA) and phosphotyrosine, and detected 
by the enhanced chemiluminescence system (Amersham, 
USA) as previous reported[8]. Digital images were acquired 
and processed using Adobe Photoshop (Adobe, Mountain View, 
CA) and quantified as described previously[15].
2.7. Statistical Analysis
  Data was expressed as mean依standard deviation (SD) and 
analyzed by one-way ANOVA and q test using SPSS 12.0. A P 
value less than 0.05 was considered statistically significant.
3. Results
3.1. Release of HGF by sporozoite-infected hepatocytes
  Primary hepatocytes were infected with sporozoites and 
the supernatants of sporozoire infected heaptocytes were 
collected after various incubation times. HGF levels, as 
determined by ELISA (Figure 1A) and Western blot analysis 
(Figure 1B), increased with time and reached it peak at 
about 3 h. The levels of HGF at time 0, 1, 1.5, 2, 2.5, 3 and 
3.5 h  were 79.1暲21.7, 103.6暲32.7, 207.4暲54.9, 348.9
暲82.5, 515.3暲104.6, 158.7暲38.3, respectively. However, 
the control hepatocytes without infecting with sporozoites 
showed negative results in both ELISA and Western blot 
(data no shown). In order to directly demonstrate HGF 
production by sporozoite infection, we combined FITC-
conjugated dextran assays for cell wounding with staining 
for HGF production in individual cells in vitro. FITC-
conjugated dextran can only penetrate wounded cell 
membranes[2]. Sporozoites were incubated with hepatocyte 
monolayer in the presence of FITC-dextran before staining 
for HGF. As show in Figure 1C and D, dextran-positive cells 
were also HGF-positive, whereas dextran-negative cells did 
not express HGF (data no shown). These results suggested 
that hepatocytes infected by sporozoites were wounded and 
HGF was expressed and released during this procedure.
3.2. Correlation of HGF with malaria infection
  To examine whether the malaria infection is mediated 
by HGF, primary hepatocytes were pre-incubated with 
recombinant murine HGF (rHGF) before addition of P. 
berghei sporozoites. As positive and negative controls, 
we pre-incubated primary hepatocytes with conditioned 
medium or fresh medium, respectively. rHGF increased 
infection rate to a greater extent than fresh medium (fMed), 
but similar to that found in the positive conditional medium 
(cMed, Figure 2A), 972.7暲203.5 in rHGF group versus 
902.9暲179.2 in cMed group and 413.8暲84.9 in the fMed 
group. There was significant difference between rHGF group 
and fMed group (P<0.01). In addition, we still observed that 
rHGF reached its peak activity in 3 h, consistent with the 
results found in the above Western blot results (Figure 2B). 
These results showed that HGF was correlated with malaria 
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infection, and suggested that HGF release was a prerequisite 
for sporozoite infection of hepatocytes.
Figure 1.  HGF expression detected by ELISA (A) and Western 
blotting (B) after hepatocyte  injury by sporozoites. Injury cell was 
performed by FITC-dextran absorption (C) and HGF expression was 
shown to be expressed in the same injury cells by immunofluorescence 
against HGF (D).
Figure 2.  Recombinant HGF increased malarial infection (A), and 
the same concentration of recombinant HGF reached the best effects 
at about 3 h (B).
3.3. Neutralization of both HGF and MET inhibited malaria 
infection
  To further confirm that HGF and its receptor MET were 
correlated with malaria infection, we added neutralizing 
monoclonal antibodies against HGF or MET to the culture 
medium before incubation with primary hepatocytes and 
sporozoites. In addition, we applied antibody against 
fibroblast growth factor (FGF) as a negative control. We 
found that the both antibodies against HGF or MET not only 
abolished the infectious effects of conditioned medium 
(cMed), but also decreased infection even below the basic 
level observed in fresh-medium cultures (fMed, Figure 3A 
and B). However, antibody against FGF showed no effects 
(Figure 3A). These results indicated that both HGF and 
MET involved the sporozoites infection and liver stage 
development.
3.4. Activation of HGF/MET signaling pathway was require 
for hepatocyte infection
  MET is the tyrosine kinase receptor for HGF[16], we thus 
considered that HGF/MET signaling activation would be 
required for the malaria infection. In this study, we used 
MET immunoprecipitation and detection of phosphorylation. 
Primary hepatocytes were incubated with P. berghei 
sporozoites for 1 h as testing group (Figure 4B, t group) and 
the control group (Figure 4B, c group) were not incubated 
with P. berghei sporozoites, activation of MET kinase was 
observed which was indicated by tyrosine phosphorylation 
of the receptor (Figure 4A), the quantitated units in t group 
(Figure 4A, lane 2) and c group (Figure 4A, lane 1) were 21.8
暲4.3 and 7.3暲1.6, respectively, suggesting that activation 
of HGF/MET signaling pathway was require for hepatocyte 
infection.
Figure 3.  Both monoclonal antibody against HGF (A) and antibody 
against HGF receptor, MET (B) , inhibited sporozoite infection of 
hepatocytes. However, monoclonal antibody against FGF did not effect 
on the sporozoite infection (A).
 
Figure 4.  Activation of HGF/MET signaling pathway was require 
for liver infection by malaria. Sporozoites infected hepatocytes (B: t 
group) were phosphorylated (A: lane 2), non-infected hepatocytes (B: 
c group) show negative (A: lane 1), indicating HGF/MET signaling 
activation during the period of sporozoite infecting of host hepatocyt.
4. Discussion
  Malaria infection begins with injection of Plasmodium 
sporozoites from a mosquito into human hosts. Thereafter, 
the sporozoites migrate to the host liver, wound and invade 
hepatocytes, and transform into EEFs that further develop 
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to produce schizonts containing thousands of merozoites 
that are released into the host blood stream and invade 
erythrocytes[1,16].It is the blood stages of malaria that 
are responsible for developing the clinical symptoms 
of the malaria disease. It is thus obvious that infection 
of liver by sporozoites is an obligate stage for malaria 
invasion of human hosts. The liver stage of Plasmodium 
is an asymptomatic stage[16]. The liver stage of malaria 
parasites produces various red cell-infectious merozoites 
within its host hepatocytes. It is thought that the vacuole-
enclosed parasite completely depends on the host cell for 
successful development but the molecular parasite–host 
cell interactions underlying this remarkable growth have 
remained unknown[17,18].  We hypothesis that it may be the 
liver specific microenvironment that provides sporozoites 
various unknown growth factors that further promote the 
sporozoites to transform and develop. In our current study, 
we demonstrated that HGF was released after sporozoites 
invade the hepatocytes. Thus, HGF is necessary for malaria 
sporozoite transforming and further developing in liver. 
  Recently, Mueller and his colleagues reported two putative 
small transmembrane proteins, UIS3 and UIS4 (up-regulated 
in infective sporozoites, UIS), in the liver stages of the rodent 
malaria parasite P. berghei[19,20]. Targeted gene deletion 
showed that UIS3 and UIS4 are only essential for liver 
stage growth and development.[19,20] . UIS4 was localized 
to the liver stage parasitophorous vacuole membrane[19]. 
However, UIS3 interacts directly with liver-fatty acid 
binding protein (L-FABP) and down-regulation of L-FABP 
expression in hepatocytes and over-expression of L-FABP 
promotes malaria sporozoites growth[21]. Theses study results 
indicate that malaria parasites do express certain proteins to 
interact with host molecules and it is such interactions that 
promote the malaria parasites further developments in the 
hapatocytes. 
  Malaria infection needs the entrance of sporozoites into 
hepatorytes through the formation of a parasitophorous 
vacuole[17, 18] . This process remains poorly understood. 
Its initial steps involve CD81 and heparan sulfate 
proteoglycans[12,23]. In our current study, we test a well楟
known growth factor(HGF) that is reported to be released 
after hepatocyte injury. We found that injury of hepatocytes 
by sporozoite migration induces secretion of HGF and it was 
HGF that rendered hepatocytes susceptible to Plasmodium-
sporozoite infection. In addition, hepatocyte infections 
depend on activation of the HGF and its receptor signaling 
pathway. Our results indicate that HGF and its receptor may 
possibly be potential targets for new approaches to malaria 
treatment.
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